Olema Pharmaceuticals
$15.39
35
+$0.48+3.22% Today
Statistics
Day High
15.99
Day Low
15.06
52W High
36.26
52W Low
2.86
Volume
228,205
Avg. Volume
1,691,180
Mkt Cap
1.06B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12MayExpected
Expected EPS
-0.530743
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-258.95MNet Income
Analyst Ratings
$44.89Average Price Target
The highest estimate is 62.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy 91%
Hold 9%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow OLMA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Puma Biotechnology
PBYI
Mkt Cap256.89M
Gilead Sciences
GILD
Mkt Cap148.78B
Novartis
NVS
Mkt Cap237.61B
Merck
MRK
Mkt Cap214.76B
Roche
RHHBY
Mkt Cap258.9B
Astrazeneca
AZN
Mkt Cap256.58B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
AMGEN
AMGN
Mkt Cap160.66B
Pfizer
PFE
Mkt Cap140.15B
Johnson & Johnson
JNJ
Mkt Cap455.04B
About
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Show more...
CEO
Dr. Sean P. Bohen M.D., Ph.D.
Employees
96
Country
US
ISIN
US68062P1066
Listings
0 Comments
Share your thoughts
FAQ
What is Olema Pharmaceuticals stock price today?▼
The current price of OLMA is $15.39 USD — it has increased by +3.22% in the past 24 hours. Watch Olema Pharmaceuticals stock price performance more closely on the chart.
What is Olema Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Olema Pharmaceuticals stocks are traded under the ticker OLMA.
Is Olema Pharmaceuticals stock price growing?▼
OLMA stock has risen by +7.97% compared to the previous week, the month change is a -36.78% fall, over the last year Olema Pharmaceuticals has showed a +358.08% increase.
What is Olema Pharmaceuticals market cap?▼
Today Olema Pharmaceuticals has the market capitalization of 1.06B
When is the next Olema Pharmaceuticals earnings date?▼
Olema Pharmaceuticals is going to release the next earnings report on May 12, 2026.
What were Olema Pharmaceuticals earnings last quarter?▼
OLMA earnings for the last quarter are -0.5 USD per share, whereas the estimation was -0.51 USD resulting in a +2.73% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Olema Pharmaceuticals revenue for the last year?▼
Olema Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Olema Pharmaceuticals net income for the last year?▼
OLMA net income for the last year is -258.95M USD.
How many employees does Olema Pharmaceuticals have?▼
As of April 01, 2026, the company has 96 employees.
In which sector is Olema Pharmaceuticals located?▼
Olema Pharmaceuticals operates in the Health Care sector.
When did Olema Pharmaceuticals complete a stock split?▼
Olema Pharmaceuticals has not had any recent stock splits.
Where is Olema Pharmaceuticals headquartered?▼
Olema Pharmaceuticals is headquartered in San Francisco, US.